Bayer – Global Home

Explore Your Topic

Update on COVID-19

Our Commitment during the Coronavirus Pandemic

The Sustainability Council of Bayer

Coronavirus

How Close Are We to Finding a Treatment for COVID-19?

Annual Stockholders’ Meeting of Bayer AG

Coronavirus: Back To A Degree Of Normality

Investor Conference Call on the 1^st Quarter

Focusing on the Heart of the Action

Transgender At Bayer

Nicole’s Coming Out At Her Workplace

Coronavirus

An Active Substance From Bayer Could Help

Blog by Matthias Berninger

Unite behind Science!

Bayer Employees in China

Fighting the Coronavirus as one team

Blog by Cristina Alonso

Our Commitment to Safe Pesticide Solutions

Annual Report 2019

Bayer Strategically and Operationally Successful

LinkedIn Blog by
Matthias Berninger

The Clock Is Running - It's Time to Act

Recording

Investor Conference Call: Crop Science R&D Pipeline Update

February 27, 2020

Financial News Conference: Full Year 2019 Results

Media Call: Crop Science R&D Pipeline Showcase

Leaps by Bayer

New Investment to Address the Global Organ Shortage Crisis

Blog Post by Werner Baumann

Business and Sustainability Must Go Hand-in-Hand

Blog Post by Liam Condon

How to Take Agriculture Forward Together

Alpha Emitters

Deploying Antibodies to Deliver Targeted Radiation Energy

Industrial Processes

Making Chemistry greener

Discovering Hands

Visually Impaired Can Detect Breast Cancer Earlier

Investor Conference Call

Bayer 2030 Sustainable Development Objectives

Interview

Bananas At Risk

How to Recognize a Stroke

Portrait Professor Tobias Erb

Boosting CO2 Reduction with Synthetic Biology

Leaps by Bayer

New Investment to Address the Global Organ Shortage Crisis

Quarterly Statement Q3 2019

Encouraging Business Performance Across all Divisions

Menstrual Cups Are Helping Schoolgirls in Africa

Science and Society

What Do We Really Think about Science?

Anniversary (information in Spanish)

Celebrating 120 Years of Bayer in Spain

Quarterly Statement Q3 2019

Encouraging Business Performance Across all Divisions

Follow the Panel Sessions - Recording

Future of Farming Dialogue 2019

Interview with
Prof. Dr. Gunther Hirschfelder

“We Must Not Undemocratize Food Issues”

Interview with Matthias Berninger

Bayer Supports Coalition to Protect Amazon Rainforest

We listened. We learned.

Our Commitments on Transparency, Sustainability and Engagement

Bayer acquires BlueRock Therapeutics to build leading position in cell therapy

Healthcare

Maria Is Determined to Fight Her Bowel Cancer

Half-Year Report 2019

Bayer on track in operational business

For Healthcare Professionals Only:

Our Oncology Development Pipeline

Health

How to Combat the Spread of Neglected Tropical Diseases

Leaps by Bayer

New Investment for the Next Generation Immuno-Oncology

Dr. Hartmut Klusik:

"We Take Diversity And Inclusion Very Seriously”

Transparency Initiative

Further Bayer Safety Studies Accessible

Agriculture

Modern Breeding in Organic Farming

Demographic Shift

Bayer Is Committed to Healthy Aging

BLEND Community

Bayer Staff Champion Diversity

Biodiversity

The Importance
of Variety

BLEND Community

Vanessa Lived Most of Her Life as a Man

Bayer Corporate Blog

Amelie Can
Rely on Her Assistance Dog

Werner Baumann:

"Europe Needs a Culture of Opportunity"

Bayer Corporate Blog

What Does the IPBES Assessment of Biodiversity Mean for Bayer?

Challenges in Agriculture

Two Farmers,
Two Worlds

Quarterly Statement Q1 2019

Strong Operational Start to the Year

Allergies & Asthma

Are you Allergic to your own Home?

Latest News

Share Price / Index

May 22, 2020

Not intended for U.S. and UK Media

Bayer submits larotrectinib for marketing authorization in Japan for the treatment of TRK fusion cancer

May 19, 2020

Nine internationally recognized experts join Sustainability Council

Independent external council to advise Bayer’s Board of Management on consistent implementation of its sustainability targets

May 13, 2020

Not intended for U.S. and UK Media - New ARAMIS Phase III data to be presented at the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program

Nubeqa™ (darolutamide) significantly improved overall survival with a favorable safety profile in men with non-metastatic prostate cancer

News Overview

Advance Your Career

Career

Why Bayer

Working at Bayer

Meet Our Employees

Open Jobs

Explore Our Businesses

We address some of the world's most pressing global challenges and continue to develop new solutions. The population is constantly growing and its age is increasing. That is why it needs better medicines and high-quality food in sufficient quantities. Learn more about it here.

Pharmaceuticals

Consumer Health

Crop Science

Animal Health

Find Your Product

With our products we contribute to the health of people, animals and plants. Here you find an overview of the major Bayer products.

Can We Live Better?

Challenges of a Better Tomorrow

Aging Population, big data, prenatal nutrition, water scarcity, animal-human bond: Bayer engages in a conversation about the future that matters the most to you – your own.

Can Food Supply Chains Cope with COVID-19?

Explore Your Topic

Our Commitment during the Coronavirus Pandemic

The Sustainability Council of Bayer

How Close Are We to Finding a Treatment for COVID-19?

Our Products

If you could cure the incurable, would you?

Should intimate health problems be taboo or treatable?

Can we grow more from less?

Can 10 billion of us live better?

Are we becoming allergic to the 21st century?

The Pollen Problem

How Farmers Are Keeping Us Fed through the Global Crisis

Let’s Talk About Glyphosate

Good start to 2020 – activities marked by COVID-19

Science at Home with Bayer

Annual Stockholders’ Meeting of Bayer AG

Coronavirus: Back To A Degree Of Normality

Investor Conference Call on the 1st Quarter

Focusing on the Heart of the Action

Nicole’s Coming Out At Her Workplace

An Active Substance From Bayer Could Help

Unite behind Science!

Fighting the Coronavirus as one team

Our Commitment to Safe Pesticide Solutions

Bayer Strategically and Operationally Successful

The Clock Is Running - It's Time to Act

Investor Conference Call: Crop Science R&D Pipeline Update

Financial News Conference: Full Year 2019 Results

Media Call: Crop Science R&D Pipeline Showcase

New Investment to Address the Global Organ Shortage Crisis

Business and Sustainability Must Go Hand-in-Hand

How to Take Agriculture Forward Together

Deploying Antibodies to Deliver Targeted Radiation Energy

Making Chemistry greener

Visually Impaired Can Detect Breast Cancer Earlier

Bayer 2030 Sustainable Development Objectives

Bananas At Risk

How to Recognize a Stroke

Boosting CO2 Reduction with Synthetic Biology

New Investment to Address the Global Organ Shortage Crisis

Encouraging Business Performance Across all Divisions

Menstrual Cups Are Helping Schoolgirls in Africa

What Do We Really Think about Science?

Celebrating 120 Years of Bayer in Spain

Encouraging Business Performance Across all Divisions

Future of Farming Dialogue 2019

“We Must Not Undemocratize Food Issues”

Bayer Supports Coalition to Protect Amazon Rainforest

Our Commitments on Transparency, Sustainability and Engagement

Bayer acquires BlueRock Therapeutics to build leading position in cell therapy

Maria Is Determined to Fight Her Bowel Cancer

Bayer on track in operational business

Our Oncology Development Pipeline

How to Combat the Spread of Neglected Tropical Diseases

New Investment for the Next Generation Immuno-Oncology

"We Take Diversity And Inclusion Very Seriously”

Further Bayer Safety Studies Accessible

Modern Breeding in Organic Farming

Bayer Is Committed to Healthy Aging

Bayer Staff Champion Diversity

The Importanceof Variety

Vanessa Lived Most of Her Life as a Man

Amelie CanRely on Her Assistance Dog

"Europe Needs a Culture of Opportunity"

What Does the IPBES Assessment of Biodiversity Mean for Bayer?

Two Farmers,Two Worlds

Strong Operational Start to the Year

Are you Allergic to your own Home?

Links

Latest News

Share Price / Index

Bayer submits larotrectinib for marketing authorization in Japan for the treatment of TRK fusion cancer

Independent external council to advise Bayer’s Board of Management on consistent implementation of its sustainability targets

Nubeqa™ (darolutamide) significantly improved overall survival with a favorable safety profile in men with non-metastatic prostate cancer

Advance Your Career

Why Bayer

Meet Our Employees

Open Jobs

Explore Our Businesses

Investor Conference Call on the 1^st Quarter

The Importance
of Variety

Amelie Can
Rely on Her Assistance Dog

Two Farmers,
Two Worlds